These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 1756133

  • 1. Clinical relevance of myocardial "stunning".
    Bolli R, Hartley CJ, Rabinovitz RS.
    Cardiovasc Drugs Ther; 1991 Oct; 5(5):877-90. PubMed ID: 1756133
    [Abstract] [Full Text] [Related]

  • 2. Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: a possible manifestation of myocardial stunning.
    Jeroudi MO, Cheirif J, Habib G, Bolli R.
    Am Heart J; 1994 May; 127(5):1241-50. PubMed ID: 8172052
    [Abstract] [Full Text] [Related]

  • 3. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.
    Kloner RA, Jennings RB.
    Circulation; 2001 Dec 11; 104(24):2981-9. PubMed ID: 11739316
    [Abstract] [Full Text] [Related]

  • 4. [Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].
    Heusch G.
    Z Kardiol; 1992 Nov 11; 81(11):596-609. PubMed ID: 1471397
    [Abstract] [Full Text] [Related]

  • 5. Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: direct evidence for myocardial stunning in humans.
    Gerber BL, Wijns W, Vanoverschelde JL, Heyndrickx GR, De Bruyne B, Bartunek J, Melin JA.
    J Am Coll Cardiol; 1999 Dec 11; 34(7):1939-46. PubMed ID: 10588207
    [Abstract] [Full Text] [Related]

  • 6. Basic and clinical aspects of myocardial stunning.
    Bolli R.
    Prog Cardiovasc Dis; 1998 Dec 11; 40(6):477-516. PubMed ID: 9647607
    [Abstract] [Full Text] [Related]

  • 7. Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation.
    Ferrari R, Ceconi C, Curello S, Benigno M, La Canna G, Visioli O.
    J Cardiovasc Pharmacol; 1996 Dec 11; 28 Suppl 1():S18-26. PubMed ID: 8891867
    [Abstract] [Full Text] [Related]

  • 8. Molecular and cellular mechanisms of myocardial stunning.
    Bolli R, Marbán E.
    Physiol Rev; 1999 Apr 11; 79(2):609-34. PubMed ID: 10221990
    [Abstract] [Full Text] [Related]

  • 9. Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease.
    Sheiban I, Tonni S, Marini A, Trevi G.
    Am J Cardiol; 1995 Apr 27; 75(13):23E-30E. PubMed ID: 7726120
    [Abstract] [Full Text] [Related]

  • 10. [Reversible left ventricular dysfunction in coronary disease (part one): myocardial stunning].
    Vlahović A, Popović A.
    Med Pregl; 2000 Apr 27; 53(1-2):39-44. PubMed ID: 10953549
    [Abstract] [Full Text] [Related]

  • 11. Hibernating myocardium, stunning, ischemic preconditioning: clinical relevance.
    Futterman LG, Lemberg L.
    Am J Crit Care; 2000 Nov 27; 9(6):430-6. PubMed ID: 11072559
    [Abstract] [Full Text] [Related]

  • 12. Stunning: damaging or protective to the myocardium?
    Ferrari R, Visioli O.
    Cardiovasc Drugs Ther; 1991 Oct 27; 5(5):939-45. PubMed ID: 1756141
    [Abstract] [Full Text] [Related]

  • 13. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2.
    Kloner RA, Jennings RB.
    Circulation; 2001 Dec 18; 104(25):3158-67. PubMed ID: 11748117
    [Abstract] [Full Text] [Related]

  • 14. The reduction of infarct size--forty years of research.
    Ferreira R.
    Rev Port Cardiol; 2010 Jun 18; 29(6):1037-53. PubMed ID: 20964114
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium.
    Vanoverschelde JL, Wijns W, Depré C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA.
    Circulation; 1993 May 18; 87(5):1513-23. PubMed ID: 8491006
    [Abstract] [Full Text] [Related]

  • 16. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation.
    Ross J.
    Circulation; 1991 Mar 18; 83(3):1076-83. PubMed ID: 1999010
    [Abstract] [Full Text] [Related]

  • 17. Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning.
    Sheiban I, Tonni S, Benussi P, Marini A, Trevi GP.
    Eur Heart J; 1993 Jul 18; 14 Suppl A():14-21. PubMed ID: 8370356
    [Abstract] [Full Text] [Related]

  • 18. The pathophysiology of myocardial stunning: reversibility, accumulation and continuity of the ischemic myocardial damage after reperfusion.
    Miura M, Matsu-oka H, Saito T, Kanazawa T.
    Jpn Circ J; 1991 Sep 18; 55(9):868-77. PubMed ID: 1658410
    [Abstract] [Full Text] [Related]

  • 19. Stunning of the myocardium: an update.
    Braunwald E.
    Cardiovasc Drugs Ther; 1991 Oct 18; 5(5):849-51. PubMed ID: 1756130
    [Abstract] [Full Text] [Related]

  • 20. Myocardial blood flow, function, and metabolism in repetitive stunning.
    Di Carli MF, Prcevski P, Singh TP, Janisse J, Ager J, Muzik O, Vander Heide R.
    J Nucl Med; 2000 Jul 18; 41(7):1227-34. PubMed ID: 10914914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.